EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Prolonged Follow‐Up in a 30‐Year‐Old Male With a Novel Pathogenic Variant in MSL3 : A Case Report and a Brief Review of the Literature

Giulia Pisanò iD, Carlo Alberto Cesaroni iD, Susanna Rizzi, Agnese Pantani, Anna Cavalli iD, Stefano Giuseppe Caraffi, Simonetta Rosato, Camilla Stefanini, Martina Gnazzo, Livia Garavelli iD, Daniele Frattini, Carlo Fusco

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.64196 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Giulia Pisanò und 11 weiteren Autor:innen. Beteiligte Einrichtung: Struttura Complessa di Neuropsichiatria Infantile, Dipartimento Materno-Infantile, Azienda USL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy. Hauptthemen laut MEDLINE: Intellectual Disability. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Basilicata‐Akhtar syndrome (BAS) is an ultra‐rare X‐linked neurodevelopmental disorder caused by pathogenic variants in the MSL3 gene, critical for histone H4 acetylation and chromatin regulation. To date, only 42 cases have been documented, affecting both males and females, with most variants being de novo and loss‐of‐function. We present a case of a 30‐year‐old male with BAS, exhibiting developmental delay, intellectual disability, hypotonia, motor disturbances, and dysmorphic features. Genetic testing revealed a novel de novo hemizygous variant in the MSL3 gene (NM_078629:c.1293G > A, NP_523353.2:p.(Trp431*)), leading to loss of function. Neuroimaging showed multifocal leukoencephalopathy, and the individual is receiving treatment with carbidopa‐levodopa with improvement in bradykinesia and camptocormia. This case expands our understanding of BAS and highlights the importance of genetic testing, especially Exome Sequencing (ES), in diagnosing rare conditions. Early diagnosis and multidisciplinary care are crucial for managing BAS and improving outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual DisabilityAdultHumansMaleExome SequencingFollow-Up StudiesMutationPhenotypeChromosomal Proteins, Non-HistoneDNA-Binding Proteins

Substanzen

MSL3 protein, humanChromosomal Proteins, Non-HistoneDNA-Binding Proteins

Autor:innen und Institutionen

  • Struttura Complessa di Neuropsichiatria Infantile, Dipartimento Materno-Infantile, Azienda USL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
  • Postgraduate Training in Child Neuropsychiatry, University of Study of Modena e Reggio Emilia, Modena, Italy.
  • Laboratorio di Neurofisiologia Pediatrica, Dipartimento Materno-Infantile, Azienda USL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
  • Struttura Complessa di Genetica Medica, Azienda USL-IRCCS Di Reggio Emilia, Dipartimento Materno-Infantile, Italy.

ORCID-Profile: Giulia Pisanò, Carlo Alberto Cesaroni, Anna Cavalli, Livia Garavelli

Zitieren

APA

Pisanò, G., Cesaroni, C. A., Rizzi, S., Pantani, A., Cavalli, A., Caraffi, S. G., Rosato, S., Stefanini, C., Gnazzo, M., Garavelli, L., Frattini, D., & Fusco, C. (2025). Prolonged Follow‐Up in a 30‐Year‐Old Male With a Novel Pathogenic Variant in MSL3 : A Case Report and a Brief Review of the Literature. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64196

Vancouver

Pisanò G, Cesaroni CA, Rizzi S, Pantani A, Cavalli A, Caraffi SG, et al. Prolonged Follow‐Up in a 30‐Year‐Old Male With a Novel Pathogenic Variant in MSL3 : A Case Report and a Brief Review of the Literature. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64196

BibTeX
@article{Pisan2025,
  author = {Pisanò, Giulia and Cesaroni, Carlo Alberto and Rizzi, Susanna and Pantani, Agnese and Cavalli, Anna and Caraffi, Stefano Giuseppe and Rosato, Simonetta and Stefanini, Camilla and Gnazzo, Martina and Garavelli, Livia and Frattini, Daniele and Fusco, Carlo},
  title = {Prolonged Follow‐Up in a 30‐Year‐Old Male With a Novel Pathogenic Variant in MSL3 : A Case Report and a Brief Review of the Literature},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.64196}
}
Kostenlos starten →